Assyro AI

Orange Book product · Brand (NDA)

ABILIFY ASIMTUFII

ARIPIPRAZOLE

Brand (NDA)NDA 217006RX OTSUKA

At a glance

Apr 27, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

8

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 27, 2023

    3 yr 2 mo ago

  2. Today

  3. Patent 10517951 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  4. Patent 10517951 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  5. Patent 11097007 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  6. Patent 11097007 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  7. Patent 11638757 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  8. Patent 11638757 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  9. Patent 12016927 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

  10. Patent 12016927 expires

    Listed drug product patent expiration.

    Apr 23, 2033

    in 6 yr 11 mo

Pharmaceutical detail

Active ingredient

ARIPIPRAZOLE

Strength

720MG/2.4ML (300MG/ML)

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

TE code

Not listed

Application

NDA 217006

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (8)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10517951Apr 23, 2033in 6 yr 11 mo
ProductU-3245
10517951Apr 23, 2033in 6 yr 11 mo
ProductU-814
11097007Apr 23, 2033in 6 yr 11 mo
ProductU-3245
11097007Apr 23, 2033in 6 yr 11 mo
ProductU-814
11638757Apr 23, 2033in 6 yr 11 mo
ProductU-3245
11638757Apr 23, 2033in 6 yr 11 mo
ProductU-814
12016927Apr 23, 2033in 6 yr 11 mo
ProductU-3245
12016927Apr 23, 2033in 6 yr 11 mo
ProductU-543
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.